Literatura académica sobre el tema "Leukemia inhibitory factor"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Leukemia inhibitory factor".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Leukemia inhibitory factor"
Nicola, Nicos A. y Jeffrey J. Babon. "Leukemia inhibitory factor (LIF)". Cytokine & Growth Factor Reviews 26, n.º 5 (octubre de 2015): 533–44. http://dx.doi.org/10.1016/j.cytogfr.2015.07.001.
Texto completoMetcalf, Donald. "The leukemia inhibitory factor (LIF)". International Journal of Cell Cloning 9, n.º 2 (1991): 95–108. http://dx.doi.org/10.1002/stem.5530090201.
Texto completoVanchieri, C. "Leukemia Inhibitory Factor Has Multiple Personalities". JNCI Journal of the National Cancer Institute 86, n.º 4 (16 de febrero de 1994): 262. http://dx.doi.org/10.1093/jnci/86.4.262.
Texto completoHinds, Mark G., Till Maurer, Jian-Guo Zhang, Nicos A. Nicola y Raymond S. Norton. "Solution Structure of Leukemia Inhibitory Factor". Journal of Biological Chemistry 273, n.º 22 (29 de mayo de 1998): 13738–45. http://dx.doi.org/10.1074/jbc.273.22.13738.
Texto completoSenturk, Levent M. y Aydin Arici. "Leukemia Inhibitory Factor in Human Reproduction". American Journal of Reproductive Immunology 39, n.º 2 (febrero de 1998): 144–51. http://dx.doi.org/10.1111/j.1600-0897.1998.tb00346.x.
Texto completoRAY, DAVID W., SONG-GUANG REN y SHLOMO MELMED. "Leukemia Inhibitory Factor Regulates Proopiomelanocortin Transcriptiona". Annals of the New York Academy of Sciences 840, n.º 1 (mayo de 1998): 162–73. http://dx.doi.org/10.1111/j.1749-6632.1998.tb09560.x.
Texto completoLass, Amir, Weishui Weiser, Alain Munafo y Ernest Loumaye. "Leukemia inhibitory factor in human reproduction". Fertility and Sterility 76, n.º 6 (diciembre de 2001): 1091–96. http://dx.doi.org/10.1016/s0015-0282(01)02878-3.
Texto completoHilton, Douglas J. y Nicholas M. Gough. "Leukemia inhibitory factor: A biological perspective". Journal of Cellular Biochemistry 46, n.º 1 (mayo de 1991): 21–26. http://dx.doi.org/10.1002/jcb.240460105.
Texto completoPehlivan, Melek, Ceyda Caliskan, Zeynep Yuce y Hakkı Ogun Sercan. "Forced expression of Wnt antagonists sFRP1 and WIF1 sensitizes chronic myeloid leukemia cells to tyrosine kinase inhibitors". Tumor Biology 39, n.º 5 (mayo de 2017): 101042831770165. http://dx.doi.org/10.1177/1010428317701654.
Texto completoPepper, M. S., N. Ferrara, L. Orci y R. Montesano. "Leukemia inhibitory factor (LIF) inhibits angiogenesis in vitro". Journal of Cell Science 108, n.º 1 (1 de enero de 1995): 73–83. http://dx.doi.org/10.1242/jcs.108.1.73.
Texto completoTesis sobre el tema "Leukemia inhibitory factor"
Voyle, Roger Bruce. "Mechanisms of intracellular and extracellular cytokine production from the human leukaemia inhibitory factor gene". Title page, contents and summary only, 1999. http://web4.library.adelaide.edu.au/theses/09PH/09phv975.pdf.
Texto completoHaines, Bryan Peter. "Alternate transcription and translation of the LIF gene produces a novel intracellular protein /". Title page, contents and summary only, 1997. http://web4.library.adelaide.edu.au/theses/09PH/09phh1518.pdf.
Texto completoZhang, Xiyuan. "The expression of human leukemia inhibitory factor in Pichia pastoris". Thesis, The University of Sydney, 2022. https://hdl.handle.net/2123/29919.
Texto completoHsu, Li-Wei. "Structure and expression of murine leukemia inhibitory factor (LIF) gene". Thesis, University of Oxford, 1993. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.334839.
Texto completoDavis, Stephanie. "Leukemia Inhibitory Factor as a Neuroprotective Agent against Focal Cerebral Ischemia". Scholar Commons, 2016. http://scholarcommons.usf.edu/etd/6218.
Texto completoSchiemann, William Paul. "Determination and characterization of leukemia inhibitory factor receptor signal transduction systems /". Thesis, Connect to this title online; UW restricted, 1996. http://hdl.handle.net/1773/6277.
Texto completoNg, Yu Pong. "Leukemia inhibitory factor receptor signaling in NGF-induced neuronal differentiation of PC12 cells /". View abstract or full-text, 2004. http://library.ust.hk/cgi/db/thesis.pl?BICH%202004%20NG.
Texto completoIncludes bibliographical references (leaves 134-172). Also available in electronic version. Access restricted to campus users.
Alberti, Kristin. "Biologische Verfügbarkeit des Zytokins Leukemia inhibitory factor nach kovalenter Ankopplung an Polymeroberflächen". Doctoral thesis, Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden, 2011. http://nbn-resolving.de/urn:nbn:de:bsz:14-qucosa-65099.
Texto completoIn vitro cultivation of (embryonic) stem cells requires a defined environment. Together different properties as cytokine supplement, extracellular matrix composition or topographic design can mimic this stem cell niche in an artificial system. For mouse embryonic stem cells the cytokine leukemia inhibitory factor (LIF) is able to keep those cells in undifferentiated state and to enhance self renewal without the supplement of other factors. In vivo LIF exists in both diffusible and extracellular matrix immobilized form. This work investigates whether LIF can be immobilized covalently to alternating maleic anhydride (MA)-copolymers in a functional manner. When bioavailable, covalently immobilized LIF should be able to interact with specific cytokine receptor subunits and provide information to keep murine embryonic stem cells in a pluripotent state. In aqueous solution with neutral pH (such as phosphate buffered saline, PBS) and ambient temperature and pressure MA-copolymers react spontaneously with aminogroups and therefore represent a useful support for covalent protein immobilization. Depending on the choice of co-monomer, properties of copolymer vary: ethylene results in hydrophilic poly-(ethylene-alt-maleic anhydride) (PEMA), octadecene in more hydrophobic poly-(octadecene-alt-maleic anhydride) (POMA). LIF can be covalently immobilized onto the MA-copolymers as shown by radiolabeling experiments. The amount of cytokine coupled to PEMA increased linear whereas on POMA saturation could be observed for higher concentrations. A subsequent coupling of a polyethylene glycol spacer (PEG7) further modified the properties and led to more hydrophilic surfaces. The amount of LIF per area decreased in comparison to MA-copolymers without the spacer but the graph characteristics remained unaltered (linear for PEMA+PEG7, saturation for POMA+PEG7). During the first three days in buffer solution supplemented with bovine serum albumin, unbound LIF was displaced and the amount of immobilized cytokine remained stable. This Stability after preincubation allowed to immobilize required amounts of LIF per area. Although hydrophilic surfaces with PEMA showed swelling behavior resulting in increased layer thickness after incubation in PBS, accessibility to LIF for an antibody was not impaired. The amounts per area detected by radiolabeling method and using the antibody were similar and indicated that LIF was not covered by copolymers. For cell culture addition of diffusible as well as immobilized growth factors or cytokines requires dosage control. Frequently it is necessary to provide homogeneous distribution of the factor of interest. In the present study analysis by fluorescence microscopy confirmed homogeneity for surfaces with covalently immobilized LIF (iLIF) but not for LIF physisorbed to extracellular matrix components collagen type I and fibronectin. LIF transduces signals via the JAK/STAT pathway. Preliminary experiments with LIF-sensitive fibroblasts showed similar activation of STAT3 after stimulation with immobilized or diffusible LIF. The results of STAT3 activation revealed an activation profile with high intensities within the first 15 minutes for both immobilized and diffusible LIF followed by decrease. STAT3 activation profiles were similar on different surfaces and independent of LIF presentation mode. These results revealed that fibroblasts could recognize covalently immobilized LIF onto MA-copolymers and were able to activate STAT3. In the absence of LIF mESC start to differentiate within 24 to 36 hours and loose their pluripotency. To confirm the functional immobilization of LIF mouse embryonic stem cells (mESC) were cultivated on iLIF-modified POMA or POMA+PEG7 surfaces for 72 hours and stained for activated STAT3. Results showed a dose-dependent activation increasing with the iLIF amount per area. Higher amounts (8 and 75 ng/cm^2) of iLIF activated STAT3 similar to 10 ng/ml diffusible LIF. Introduction of PEG7 spacer did not further increased STAT3 activation. Both, the amount of ESC marker Oct4 and the percentage of Oct4-positive cells increased with higher amounts of iLIF and showed similar results as obtained with 10 ng/ml diffusible LIF. Murine ESC cultivated on LIF physisorbed to matrix components expressed similar amounts of transcription factor Oct4 compared to unstimulated cells. STAT3 activation and Oct4 expression in the absence of diffusible cytokine indicated a functional covalent immobilization of LIF. To confirm the pluripotency, mESC were stimulated for 6 to 8 subcultures only with iLIF, cell aggregates were fused with mouse embryos and implanted in pseudopregnant surrogate mothers. Three weeks after birth the contribution of mESC aggregates to chimera was evaluated. ESC stimulated with iLIF only contributed to chimera formation with around the same frequency as mESC cultivated with 10 ng/ml diffusible LIF. Thus, iLIF maintained pluripotency of mESC during in vitro expansion and could replace diffusible LIF. As shown by the experiments, MA-copolymers provide a support to covalently immobilize cell signaling molecules in a functional manner. This method of coupling does not need any protein modification or cross-linking treatment after protein incubation. Reaction can be carried out under sterile conditions at ambient temperature and pressure. The immobilized ligand is distributed equally on the supporting copolymer and the adjustment of required ligand amounts is possible. These properties characterize MA-copolymers as a suitable support to immobilize cell signaling molecules not only for keeping the stem cell fate but also for differentiation studies. Parts of this work were published: K. Alberti, R.E. Davey, K. Onishi, S. George, K. Salchert, F.P. Seib, M. Bornhäuser, T. Pompe, A. Nagy, C.Werner, and P.W. Zandstra. Functional immobilization of signaling proteins enables control of stem cell fate. Nat Methods, 5(7):645–650, Jul 2008. T. Pompe, K. Salchert, K. Alberti, P.W. Zandstra, and C. Werner. Immobilization of growth factors on solid supports for the modulation of stem cell fate. Nat Protocols, 5(6):1042–1050, Jun 2010
Port, Martha D. "Regulation of expression and function of neurokine receptors /". Thesis, Connect to this title online; UW restricted, 2008. http://hdl.handle.net/1773/6283.
Texto completoGascan, Hugues. "Caracterisation du facteur de croissance hilda : leukemia inhibitory factor produit par des cellules tumorales humaines". Nantes, 1988. http://www.theses.fr/1988NANT04VS.
Texto completoLibros sobre el tema "Leukemia inhibitory factor"
Paglia, Diana. The role of leukemia inhibitory factor in skin biology. Ottawa: National Library of Canada, 1996.
Buscar texto completoGregory, Bock, Marsh Joan y Widdows Kate, eds. Polyfunctional cytokines: IL-6 and LIF. Chichester, Eng: Wiley, 1992.
Buscar texto completoAthanasius, Anagostou, Dainiak Nicholas, Najman Albert y International Conference on Negative Regulators of Hematopoiesis, (2nd : 1990 : Providence, R.I.), eds. Negative regulators of hematopoiesis: Studies of their nature, action, and potential role in cancer therapy. New York, N.Y: New York Academy of Sciences, 1991.
Buscar texto completoNegative regulators of hematopoiesis: Studies on their nature, action, and potential role in cancer therapy. New York, N.Y: New York Academy of Sciences, 1991.
Buscar texto completoAnagnostou, Athanasius y Nicholas Dainiak. Negative Regulators of Hematopoiesis: Studies on Their Nature, Action, and Potential Role in Cancer Therapy (Annals of the New York Academy of Scien). New York Academy of Sciences, 1991.
Buscar texto completoNajman, Albert, Athanasius Anagnostou y Nicholas Dainiak. Negative regulators of hematopoiesis : Studies on their nature, action, and potential role in cancer therapy. New York Academy of Sciences, 1991.
Buscar texto completoCapítulos de libros sobre el tema "Leukemia inhibitory factor"
Ratajczak, Mariusz Z. "Leukemia Inhibitory Factor". En Encyclopedia of Cancer, 1–3. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-27841-9_3324-4.
Texto completoRatajczak, Mariusz Z. "Leukemia Inhibitory Factor". En Encyclopedia of Cancer, 2473–75. Berlin, Heidelberg: Springer Berlin Heidelberg, 2017. http://dx.doi.org/10.1007/978-3-662-46875-3_3324.
Texto completoRatajczak, Mariusz Z. "Leukemia Inhibitory Factor". En Encyclopedia of Cancer, 2025–27. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-16483-5_3324.
Texto completoAgca, Cavit y Christian Grimm. "Leukemia Inhibitory Factor Signaling in Degenerating Retinas". En Retinal Degenerative Diseases, 389–94. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4614-3209-8_49.
Texto completoHooper, Marcus J. y John D. Ash. "Müller Cell Biological Processes Associated with Leukemia Inhibitory Factor Expression". En Retinal Degenerative Diseases, 479–84. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-75402-4_59.
Texto completoRavandi, Farhad y Zeev Estrov. "The Role of Leukemia Inhibitory Factor in Cancer and Cancer Metastasis". En Growth Factors and their Receptors in Cancer Metastasis, 1–25. Dordrecht: Springer Netherlands, 2001. http://dx.doi.org/10.1007/0-306-48399-8_1.
Texto completoTanaka, Masato, Tatsuya Yamashita y Satoshi Terada. "The Effect of Interleukin-6 and Leukemia Inhibitory Factor on Hybridoma Cells". En Animal Cell Technology: Basic & Applied Aspects, 47–51. Dordrecht: Springer Netherlands, 2008. http://dx.doi.org/10.1007/978-1-4020-9646-4_8.
Texto completoAsh, John D. "Leukemia Inhibitory Factor Prevents Photoreceptor Cell Death in rd-/- Mice by Blocking Functional Differentiation". En New Insights Into Retinal Degenerative Diseases, 135–44. Boston, MA: Springer US, 2001. http://dx.doi.org/10.1007/978-1-4615-1355-1_16.
Texto completoTorchinsky, A., U. R. Markert y V. Toder. "TNF-&agr;-Mediated Stress-Induced Early Pregnancy Loss:A Possible Role of Leukemia Inhibitory Factor". En Chemical Immunology and Allergy, 62–71. Basel: KARGER, 2005. http://dx.doi.org/10.1159/000087913.
Texto completoFletcher, Frederick A., Kateri A. Moore, Douglas E. Williams, Dirk Anderson, Charles Maliszewski y John W. Belmont. "Effects of Leukemia Inhibitory Factor (LIF) on Gene Transfer Efficiency into Murine Hematolymphoid Progenitors". En Mechanisms of Lymphocyte Activation and Immune Regulation III, 131–38. Boston, MA: Springer US, 1991. http://dx.doi.org/10.1007/978-1-4684-5943-2_15.
Texto completoActas de conferencias sobre el tema "Leukemia inhibitory factor"
Quinton, Lee J., Joseph P. Mizgerd, Matthew R. Jones y Eri Allen. "Endogenous Leukemia Inhibitory Factor Limits Acute Lung Injury During Pneumonia". En American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a1090.
Texto completoNair, Hareesh B., Bindu Santhamma, Surya Viswanadhapa y Klaus J. Nickisch. "Abstract LB-208: First-in-class steroidal leukemia inhibitory factor (LIF) inhibitor in targeted cancer therapy". En Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-lb-208.
Texto completoPoon, J., M. A. Campos, R. F. Foronjy, S. Nath, G. Gupta, C. Railwah, A. J. Dabo, N. Baumlin, M. A. Salathe y P. Geraghty. "Cigarette Smoke Exposure Reduces Leukemia Inhibitory Factor Levels During Respiratory Syncytial Viral Infection". En American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a4517.
Texto completoChang, Xiaofei, Yong G. Cho, Il-Seok Park, Chunbo Shao, Patrick Ha, Sara I. Pai, David Sidransky y Myoung S. Kim. "Abstract 4799: Promoter methylation of leukemia inhibitory factor receptor gene in colorectal carcinoma". En Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-4799.
Texto completoNair, Hareesh B., Bindu Santhamma, Suryavathi Viswanadhapalli, Gangadhara R. Sareddy, Xinlei Pan, Vijaya Manthati, Ratna K. Vadlamudi, Murali Ramachandran y Klaus J. Nickisch. "Abstract LB-B04: Development of a first-in-class leukemia inhibitory factor (LIF)/LIFR inhibitor, EC359 for targeted therapy". En Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; October 26-30, 2017; Philadelphia, PA. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1535-7163.targ-17-lb-b04.
Texto completoNa, E., K. E. Traber, F. T. Korkmaz, Y. Kim, C. V. Odom, L. A. Baird, M. R. Jones, J. P. Mizgerd y L. J. Quinton. "Determining Epithelial-Specific Roles for the Lung-Protective Cytokine Leukemia Inhibitory Factor (LIF) During Pneumonia". En American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a6166.
Texto completoKrasnapolski, Martin A., Ana Quaglino, Edith Kordon y Elisa D. Bal de Kier Joffe. "Abstract 3121: Study of leukemia inhibitory factor (LIF) system in a murine mammary tumor comprising luminal and myoepithelial cells". En Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-3121.
Texto completoKamohara, Hidenobu, Yoshiharu Hiyoshi, Junji Kurashige, Koichi Kinoshita, Masaaki Iwatsuki y Hideo Baba. "Abstract 4111: Induction of CXCL8 by TNFalpha and LIF (Leukemia Inhibitory Factor) in pancreatic carcinoma cells: Impact of CXCL8 as an autocrine growth factor". En Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-4111.
Texto completoBanerjee, Priyanka, Baidyanath Chakravarty y Koel Chaudhury. "Expression of αvβ3 integrin, leukemia inhibitory factor and pinopodes as markers of endometrial receptivity in idiopathic recurrent spontaneous miscarriage". En 2010 International Conference on Systems in Medicine and Biology (ICSMB). IEEE, 2010. http://dx.doi.org/10.1109/icsmb.2010.5735419.
Texto completoIorns, Elizabeth J., Toby M. Ward, Sonja Dean, Anna Jegg, Nirupa Murugaesu, David Sims, Christopher Lord et al. "Abstract 4979: Whole genome in vivo RNA interference screening identifies the leukemia inhibitory factor receptor as a novel breast tumor suppressor". En Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-4979.
Texto completoInformes sobre el tema "Leukemia inhibitory factor"
Splitter, Gary, Zeev Trainin y Yacov Brenner. Lymphocyte Response to Genetically Engineered Bovine Leukemia Virus Proteins in Persistently Lymphocytic Cattle from Israel and the U.S. United States Department of Agriculture, julio de 1995. http://dx.doi.org/10.32747/1995.7570556.bard.
Texto completo